SVP, CFO of Synageva BioPharma Corp (
GEVA) Carsten Boess sells 9,927 shares of GEVA on 01/16/2013 at an average price of $49.12 a share.
Synageva Biopharma Corp has a market cap of $1.23 billion; its shares were traded at around $50.74 with and P/S ratio of 83.8.
CEO Recent Trades:
- President & CEO Sanj K Patel sold 60,000 shares of GEVA stock on 12/17/2012 at the average price of 46.21. Sanj K Patel owns at least 1,317 shares after this. The price of the stock has increased by 9.8% since.
- President & CEO Sanj K Patel sold 35,000 shares of GEVA stock on 12/05/2012 at the average price of 48.92. Sanj K Patel owns at least 1,317 shares after this. The price of the stock has increased by 3.72% since.
- President & CEO Sanj K Patel sold 35,000 shares of GEVA stock on 12/03/2012 at the average price of 49.34. Sanj K Patel owns at least 1,317 shares after this. The price of the stock has increased by 2.84% since.
- President & CEO Sanj K Patel sold 70,000 shares of GEVA stock on 09/04/2012 at the average price of 49.47. Sanj K Patel owns at least 1,317 shares after this. The price of the stock has increased by 2.57% since.
CFO Recent Trades:
- SVP, CFO Carsten Boess sold 9,927 shares of GEVA stock on 01/16/2013 at the average price of 49.12. The price of the stock has increased by 3.3% since.
- SVP, CFO Carsten Boess sold 9,927 shares of GEVA stock on 10/16/2012 at the average price of 50.13. The price of the stock has increased by 1.22% since.
Directors and Officers Recent Trades:
- Director Thomas J Tisch bought 21,039 shares of GEVA stock on 01/09/2013 at the average price of 47.53. Thomas J Tisch owns at least 751,995 shares after this. The price of the stock has increased by 6.75% since.
- Director, 10% Owner Felix Baker bought 859,720 shares of GEVA stock on 01/04/2013 at the average price of 47.53. Felix Baker owns at least 1,736,565 shares after this. The price of the stock has increased by 6.75% since.
- Director, 10% Owner Julian Baker bought 859,720 shares of GEVA stock on 01/04/2013 at the average price of 47.53. Julian Baker owns at least 1,737,085 shares after this. The price of the stock has increased by 6.75% since.
- SVP, Chief Medical Officer Anthony Quinn sold 5,553 shares of GEVA stock on 01/17/2013 at the average price of 50.07. Anthony Quinn owns at least 15,035 shares after this. The price of the stock has increased by 1.34% since.
- SVP, Product Development Mark Alan Goldberg sold 4,417 shares of GEVA stock on 01/02/2013 at the average price of 47.52. The price of the stock has increased by 6.78% since.
For the complete insider trading history of GEVA,
click here.
European Shorting
Feedback
My Portfolios
Browse Gurus
RSS